CD34+-Selected Infusions of Fresh or Cryopreserved Peripheral Blood Stem Cells for the Treatment of Poor Graft Function Following Allogeneic Hematopoietic Stem Cell Transplant

被引:1
|
作者
Ghobadi, Armin [1 ]
Fiala, Mark A. [1 ]
Ramsingh, Giridharan [2 ]
Gao, Feng [3 ]
Abboud, Camille N. [1 ]
Stockerl-Goldstein, Keith [1 ]
Uy, Geoffrey L. [4 ]
Westervelt, Peter [1 ]
DiPersio, John F. [1 ]
机构
[1] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA
[2] Univ So Calif, Hematol, Los Angeles, CA USA
[3] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Div Oncol, St Louis, MO USA
关键词
D O I
10.1182/blood.V126.23.3312.3312
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Can Planned CD34+Stem Cell Boost Prevent Poor Graft Function after Peripheral Blood Haploidentical Hematopoietic Transplantation?
    Abboud, Ramzi
    Slade, Michael
    Abboud, Camille
    DiPersio, John F.
    Xiang, Zhifu
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S296 - S296
  • [42] Treatment of poor graft function after allogeneic hematopoietic cell transplantation with a booster of CD34-selected cells infused without conditioning
    Askaa, B.
    Fischer-Nielsen, A.
    Vindelov, L.
    Haastrup, E. K.
    Sengelov, H.
    BONE MARROW TRANSPLANTATION, 2014, 49 (05) : 720 - 721
  • [43] Treatment of poor graft function after allogeneic hematopoietic cell transplantation with a booster of CD34-selected cells infused without conditioning
    B Askaa
    A Fischer-Nielsen
    L Vindeløv
    E K Haastrup
    H Sengeløv
    Bone Marrow Transplantation, 2014, 49 : 720 - 721
  • [44] Individually adjusted prophylactic donor lymphocyte infusions after CD34-selected allogeneic peripheral blood stem cell transplantation
    C Ferrá
    M Rodríguez-Luaces
    D Gallardo
    M Encuentra
    GA Martín-Henao
    J Peris
    I Ancín
    J Sarrá
    JJ Berlanga
    J García
    A Grañena
    Bone Marrow Transplantation, 2001, 28 : 963 - 968
  • [45] Intrabone injection of hematopoietic stem cells (IB-HSC) to treat poor graft function (PGF) after allogeneic hematopoietic stem cell transplant (HSCT)
    Giglio, F.
    Mannina, D.
    Morelli, M.
    Greco, R.
    Marktel, S.
    Marcatti, M.
    Stanghellini, M. T. Lupo
    Perini, T.
    Lazzari, L.
    Zambelli, M.
    Gattillo, S.
    Corti, C.
    Assanelli, A.
    Bernardi, M.
    Ciceri, F.
    Peccatori, J.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S38 - S39
  • [46] Individually adjusted prophylactic donor lymphocyte infusions after CD34-selected allogeneic peripheral blood stem cell transplantation
    Ferrá, C
    Rodríguez-Luaces, M
    Gallardo, D
    Encuentra, M
    Martín-Henao, GA
    Peris, J
    Ancín, I
    Serrá, J
    Berlangal, JJ
    García, J
    Grañena, A
    BONE MARROW TRANSPLANTATION, 2001, 28 (10) : 963 - 968
  • [47] Eltrombopag for the Treatment of Allogeneic Hematopoietic Stem Cell Transplantation-Related Poor Graft Function
    Davulcu, Eren Arslan
    Soyer, Nur Akad
    Vural, Filiz
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [48] HIGH RATE OF COMPLETE HEMATOPOIETIC RECOVERY FOLLOWING CD34+SELECTED STEM CELL BOOST IN ALLOHSCT RECIPIENTS WITH PERSISTENT POOR GRAFT FUNCTION
    Castillo, Nerea
    Fernandez-Sojo, Jesus
    Valdivia, Elena
    Azqueta, Carmen
    Martorell, Lluis
    Rubio, Nuria
    Garcia-Buendia, Ana
    Linares, Monica
    Ferrer, Gonzalo
    Garcia-Munoz, Nadia
    Diaz-de-Heredia, Cristina
    Uria, Luz
    Isabel Benitez, M.
    Fox, Laura
    Garcia-Cadenas, Irene
    Mussetti, Alberto
    Lopez-Torija, Ivan
    Delgadillo, Joaquin
    Querol, Sergio
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 377 - 377
  • [49] Allogeneic CD34+-selected peripheral stem cell transplantation from parental donors in children with non-malignant diseases
    Kremens, B
    Basu, O
    Peceny, R
    Grosse-Wilde, H
    Schaefer, UW
    Havers, W
    BONE MARROW TRANSPLANTATION, 2002, 29 (01) : 9 - 13
  • [50] Allogeneic CD34+-selected peripheral stem cell transplantation from parental donors in children with non-malignant diseases
    B Kremens
    O Basu
    R Peceny
    H Grosse-Wilde
    UW Schaefer
    W Havers
    Bone Marrow Transplantation, 2002, 29 : 9 - 13